Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds targeting central nervous system disorders. Shows potential in the development of adenosine receptor modulators for treating neurodegenerative diseases. Also explored for anti-inflammatory and analgesic applications due to its structural similarity to known pyrrolopyrimidine-based agents. Employed in preclinical studies to optimize drug candidates with improved metabolic stability and blood-brain barrier penetration.